Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
07 Oct 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Carfilzomib Haematologic malignancies - Anticancer agents & Biologic therapy
07 Oct 2015 EMA Recommends Granting a Marketing Authorisation for Blinatumomab Haematologic malignancies - Immuno-oncology
06 Oct 2015 FDA Approves Pembrolizumab for Advanced Non-Small-Cell Lung Cancer Lung and other thoracic tumours - Immuno-oncology
05 Oct 2015 FDA Approves New Oral Medication to Treat Patients With Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
28 Sep 2015 ESMO @ ECC 2015: Comprehensive Genomic Profiling Detects High Frequency of ERBB2 Extracellular Domain Mutations in Multiple Cancer Types Personalised medicine - Translational research
28 Sep 2015 ESMO @ ECC 2015: Comprehensive Genomic Profiling of BRAF in a Large Series of Lung Cancer Samples Translational research - Lung and other thoracic tumours
28 Sep 2015 ESMO @ ECC 2015: Response to EGFR Agents in Combination With Chemotherapy Demonstrated in Patients with Metastatic Colorectal Cancer of Rare KRAS Molecular Subtype Gastrointestinal cancers - Anticancer agents & Biologic therapy
27 Sep 2015 ESMO @ ECC 2015: Progression-Free Survival Prolonged with Everolimus in Patients with Advanced Lung/Gastrointestinal Neuroendocrine Tumours Endocrine cancers - Anticancer agents & Biologic therapy
27 Sep 2015 ESMO @ ECC2015: Greater Clinical Benefit Obtained in Advanced BRAFV600-mutated Melanoma with Cobimetinib/Vemurafenib Over Vemurafenib Is Consistent Across Mutation Subtypes Melanoma - Anticancer agents & Biologic therapy
27 Sep 2015 ESMO @ ECC 2015: Induction with Nivolumab Followed by Ipilimumab Most Effective Temporal Approach in Non-Resectable Melanoma Melanoma - Immuno-oncology
27 Sep 2015 ESMO @ ECC 2015: Blocking PD1 Shows Promise in Merkel Cell Carcinoma Melanoma - Immuno-oncology
27 Sep 2015 ESMO @ ECC 2015: Novel Atezolizumab Shows Promise in Metastatic Urothelial Carcinoma Genitourinary cancers - Immuno-oncology
27 Sep 2015 ESMO @ ECC 2015: Novel Assay Developed to Determine PD-L2 Expression in Tumour Samples Pathology/Molecular biology - Immuno-oncology
27 Sep 2015 ESMO Commentary: Atezolizumab Set to Change Refractory Lung Cancer Treatment Lung and other thoracic tumours - Immuno-oncology
26 Sep 2015 ESMO @ ECC 2015: Cabozantinib Out-Performs Everolimus in Advanced Renal Cell Carcinoma Genitourinary cancers - Anticancer agents & Biologic therapy